Delivery Order SPE2DB24D2010-SPE2DB25FAARL
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $8,311.84 by the Defense Logistics Agency (DLA) on April 30, 2025, for the supply of Eliquis 5 mg tablets (60-count units). The contract, which is not set-aside, utilizes firm fixed pricing and carries an ultimate completion date of May 1, 2025. Performance of this order is based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under a larger Indefinite...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $8,156.88 by the Defense Logistics Agency Medical Supply Chain on July 25, 2025, for the supply of Eliquis 5 mg tablets (60-count). The contract represents a firm fixed-price delivery order with an ultimate completion date of July 28, 2025, and is being performed at the contractor's corporate office in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation and is a child contract...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $12,049.99 by the Defense Logistics Agency (DLA) for the supply of Eliquis 5 mg tablets (60-count packages). This competitively awarded, firm fixed-price delivery order carries an ultimate completion date of August 26, 2025. The award was issued on August 25, 2025, with no set-aside designation applied. This delivery order is a child contract executed under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Eliquis 5 mg tablets in quantities of 60 units, with a ceiling value of $9,366.47. This competitive, firm fixed-price delivery order is expected to be completed by August 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order issued under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $15,665.69 by the Defense Logistics Agency (DLA) on September 10, 2025, for the supply of Eliquis 5 mg tablets in a 60-count configuration. The contract is firm fixed price with no set-aside designation, indicating competitive award to this qualified pharmaceutical distributor. The place of performance is listed as AmerisourceBergen's Corporate Office in Conshohocken, Pennsylvania, with an ultimate completion date of September...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 21, 2025, for the supply of Eliquis 5 mg tablets (60-count) with a ceiling value of $5,382.14. This is a firm fixed-price delivery order with an ultimate completion date of July 22, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen...
- AmerisourceBergen Drug Corp was awarded a delivery order from the Defense Logistics Agency (DLA) on August 28, 2025, for the supply of Eliquis 2.5 mg tablets (60 count) with a contract value of $7,862.40. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract represents a single order fulfillment under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.9 billion prime...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on June 9, 2025, for the supply of Eliquis 5 mg tablets (60-count units) with a contract ceiling value of $21,441.91. This firm fixed-price delivery order, which is not set-aside, represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Eliquis 5 mg tablets in quantities of 60 units, with a ceiling value of $16,480.94. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for ultimate completion by September 9, 2025, and performance will occur at AmerisourceBergen's corporate office location in Conshohocken,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a firm fixed-price delivery order valued at $95,223.63 by the Defense Logistics Agency (DLA) for the supply of Eliquis 5 mg tablets (60-count units). The contract, awarded August 5, 2025, with an ultimate completion date of August 6, 2025, represents a non-competitive, open-market award. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB25FAARLDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order valued at $8,180.32 by the Defense Logistics Agency (DLA) on August 5, 2025, for the supply of Eliquis 5 mg tablets (60-count units). This is a firm fixed price delivery order with an ultimate completion date of August 6, 2025, and represents a non-set-aside competitive award. The contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's prime IDC with DLA enables it to supply a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains to customers including the Defense Health Agency and the U.S. Coast Guard. This delivery order for Eliquis, an anticoagulant medication, exemplifies the company's role in fulfilling federal medical supply needs through the DLA's pharmaceutical support infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.2k | 8/5/25 |